College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Hum Vaccin Immunother. 2022 Nov 30;18(5):2073752. doi: 10.1080/21645515.2022.2073752. Epub 2022 May 27.
Herpes Zoster is a viral infection that occurs due to reactivation of the Varicella Zoster virus. A vaccine has been approved for adults aged 50 and above for the prevention of Herpes Zoster and its complications. This study aims to assess the at-risk population's awareness of the disease and its vaccine, and attitudes and practices toward the vaccine. A quantitative, observational, cross-sectional study was conducted among 420 adults above the age of 50. Non-probability, convenience sampling was used to select participants from public venues. SPSS-25 was used to analyze the data. 64.3% (n = 270) of participants heard of Herpes Zoster. 78.3% (n = 329) did not recognize the link between chickenpox and Herpes Zoster. Multiple linear regression showed that being female, Arab expatriate, or healthcare professional were the only positive predictors of Herpes Zoster knowledge. 14.8% (n = 62) heard of Herpes Zoster vaccine but 96.7% (n = 406) had not taken it. Participants with chronic diseases were 2.064 times more likely to hear about the vaccine than healthy participants (p = 0.026). Multiple linear regression showed that being a healthcare professional was the only significant predictor of Herpes Zoster vaccine knowledge. 28.1% (n = 118) were not willing to take optional vaccines. Those reluctant to take optional vaccines were 26.023 times more likely to take them if recommended by a healthcare professional (p < 0.001). Attitudes toward Herpes Zoster vaccine were generally positive; however, due to lack of knowledge, poor practices were observed. Nationwide campaigns aimed toward at-risk groups can raise awareness on Herpes Zoster and its vaccine, subsequently improving Herpes Zoster vaccination rate.
带状疱疹是一种由水痘-带状疱疹病毒再激活引起的病毒感染。一种疫苗已被批准用于预防带状疱疹及其并发症,适用于 50 岁及以上的成年人。本研究旨在评估高危人群对该疾病及其疫苗的认识、对疫苗的态度和做法。采用定量、观察性、横断面研究方法,对 420 名 50 岁以上的成年人进行了研究。采用非概率、方便抽样法,从公共场所选择参与者。使用 SPSS-25 对数据进行分析。64.3%(n=270)的参与者听说过带状疱疹。78.3%(n=329)的人没有认识到水痘和带状疱疹之间的联系。多元线性回归显示,女性、阿拉伯侨民或医疗保健专业人员是带状疱疹知识的唯一积极预测因素。14.8%(n=62)听说过带状疱疹疫苗,但 96.7%(n=406)没有接种过。患有慢性病的参与者听说过疫苗的可能性是健康参与者的 2.064 倍(p=0.026)。多元线性回归显示,医疗保健专业人员是带状疱疹疫苗知识的唯一显著预测因素。28.1%(n=118)不愿意接种可选疫苗。如果医疗保健专业人员建议接种,不愿接种可选疫苗的人接种的可能性是不建议接种的人的 26.023 倍(p<0.001)。对带状疱疹疫苗的态度普遍较为积极;然而,由于缺乏知识,观察到的做法不佳。针对高危人群的全国性运动可以提高对带状疱疹及其疫苗的认识,从而提高带状疱疹疫苗接种率。